tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Bayer’s FINEROD Study: Real-World Insights into Finerenone’s Impact on CKD and T2D
Company AnnouncementsBayer’s FINEROD Study: Real-World Insights into Finerenone’s Impact on CKD and T2D
22h ago
Bayer AG’s Finerenone Study: A Potential Breakthrough in CKD Treatment for Type 1 Diabetes
PremiumCompany Announcements
Bayer AG’s Finerenone Study: A Potential Breakthrough in CKD Treatment for Type 1 Diabetes
22h ago
Bayer’s Hemophilia A Study: Key Insights for Investors
PremiumCompany Announcements
Bayer’s Hemophilia A Study: Key Insights for Investors
22h ago
Bayer’s Finerenone Study: A Potential Game-Changer for Chronic Kidney Disease
PremiumCompany Announcements
Bayer’s Finerenone Study: A Potential Game-Changer for Chronic Kidney Disease
22h ago
Bayer’s Kovaltry Study: Key Insights for Investors
PremiumCompany Announcements
Bayer’s Kovaltry Study: Key Insights for Investors
22h ago
Bayer’s Jivi Study: Long-term Safety Insights for Hemophilia A Treatment
PremiumCompany AnnouncementsBayer’s Jivi Study: Long-term Safety Insights for Hemophilia A Treatment
22h ago
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
Premium
Company Announcements
Bayer’s Darolutamide Study: Real-World Insights into Prostate Cancer Treatment
22h ago
Bayer’s Finerenone Study: A Potential Breakthrough in Non-Diabetic CKD Treatment
Premium
Company Announcements
Bayer’s Finerenone Study: A Potential Breakthrough in Non-Diabetic CKD Treatment
2d ago
Bayer AG’s New Study on Vericiguat: A Potential Game-Changer for Heart Failure Treatment
PremiumCompany Announcements
Bayer AG’s New Study on Vericiguat: A Potential Game-Changer for Heart Failure Treatment
2d ago
Bayer AG’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
PremiumCompany Announcements
Bayer AG’s Asundexian Study: A Potential Game-Changer in Stroke Prevention
2d ago
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
PremiumCompany Announcements
Bayer’s FINE-REAL Study: Real-World Insights into Finerenone Use
2d ago
Bayer AG’s Aficamten Study: A Potential Game-Changer for Heart Disease Treatment
PremiumCompany Announcements
Bayer AG’s Aficamten Study: A Potential Game-Changer for Heart Disease Treatment
2d ago
Bayer AG’s New Study on Mirena: A Potential Game-Changer for Women’s Health?
PremiumCompany AnnouncementsBayer AG’s New Study on Mirena: A Potential Game-Changer for Women’s Health?
2d ago
Bayer sees FY25 sales EUR 46B-EUR 48B on currency-adjusted basis
Premium
The Fly
Bayer sees FY25 sales EUR 46B-EUR 48B on currency-adjusted basis
2d ago
Bayer establishes additional provisions around EUR 1.2B for Roundup litigation
Premium
The Fly
Bayer establishes additional provisions around EUR 1.2B for Roundup litigation
2d ago
Bayer ‘making headway’ on improving profitability in agricultural business
PremiumThe Fly
Bayer ‘making headway’ on improving profitability in agricultural business
2d ago
Bayer reports Q2 core EPS EUR 1.23 vs. EUR 0.94 last year
PremiumThe Fly
Bayer reports Q2 core EPS EUR 1.23 vs. EUR 0.94 last year
2d ago
Bayer affirms aim to ‘significantly’ contain litigation risk by end of 2026
PremiumThe Fly
Bayer affirms aim to ‘significantly’ contain litigation risk by end of 2026
2d ago
Bayer’s New Study on Sevabertinib: A Potential Game-Changer for Cancer Patients with Liver Impairment
PremiumCompany Announcements
Bayer’s New Study on Sevabertinib: A Potential Game-Changer for Cancer Patients with Liver Impairment
4d ago
Bayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney Health
PremiumCompany AnnouncementsBayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney Health
7d ago
Bayer’s FINEROD Study: Evaluating Finerenone in Real-World Settings
Premium
Company Announcements
Bayer’s FINEROD Study: Evaluating Finerenone in Real-World Settings
7d ago
Bayer AG’s Real-World Study on Hemophilia A Treatment: Market Insights
Premium
Company Announcements
Bayer AG’s Real-World Study on Hemophilia A Treatment: Market Insights
7d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >